Royal Bank of Canada’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.4M | Sell |
857,965
-109,628
| -11% | -$7.14M | 0.01% | 930 |
|
|
2025
Q4 | $77.6M | Sell |
967,593
-293,227
| -23% | -$19.7M | 0.01% | 755 |
|
|
2025
Q3 | $61.5M | Buy |
1,260,820
+169,285
| +16% | +$10.5M | 0.01% | 913 |
|
|
2025
Q2 | $81.4M | Buy |
1,091,535
+15,931
| +1% | +$1.05M | 0.01% | 713 |
|
|
2025
Q1 | $68.4M | Buy |
1,075,604
+27,250
| +3% | +$1.85M | 0.01% | 676 |
|
|
2024
Q4 | $81.9M | Buy |
1,048,354
+120,302
| +13% | +$9.66M | 0.02% | 641 |
|
|
2024
Q3 | $74.6M | Buy |
928,052
+136,355
| +17% | +$11M | 0.02% | 648 |
|
|
2024
Q2 | $65.5M | Buy |
791,697
+385,900
| +95% | +$33.9M | 0.01% | 661 |
|
|
2024
Q1 | $34.6M | Buy |
405,797
+225,570
| +125% | +$17.7M | 0.01% | 951 |
|
|
2023
Q4 | $15.4M | Sell |
180,227
-19,871
| -10% | -$1.72M | ﹤0.01% | 1435 |
|
|
2023
Q3 | $17.9M | Buy |
200,098
+16,360
| +9% | +$1.46M | ﹤0.01% | 1221 |
|
|
2023
Q2 | $15.6M | Buy |
183,738
+2,988
| +2% | +$253K | ﹤0.01% | 1299 |
|
|
2023
Q1 | $15M | Sell |
180,750
-26,642
| -13% | -$2.16M | ﹤0.01% | 1308 |
|
|
2022
Q4 | $16.3M | Buy |
207,392
+32,574
| +19% | +$2.62M | ﹤0.01% | 1279 |
|
|
2022
Q3 | $12.9M | Buy |
174,818
+25,406
| +17% | +$1.82M | ﹤0.01% | 1362 |
|
|
2022
Q2 | $9.74M | Sell |
149,412
-601
| -0.4% | -$35.6K | ﹤0.01% | 1582 |
|
|
2022
Q1 | $9.48M | Sell |
150,013
-154,640
| -51% | -$8.41M | ﹤0.01% | 1756 |
|
|
2021
Q4 | $16.2M | Sell |
304,653
-26,705
| -8% | -$1.63M | ﹤0.01% | 1537 |
|
|
2021
Q3 | $23.4M | Buy |
331,358
+1,440
| +0.4% | +$90.9K | 0.01% | 1232 |
|
|
2021
Q2 | $22M | Buy |
329,918
+141,402
| +75% | +$10M | 0.01% | 1274 |
|
|
2021
Q1 | $20.9M | Sell |
188,516
-87,294
| -32% | -$10.8M | 0.01% | 1247 |
|
|
2020
Q4 | $32.8M | Sell |
275,810
-60,979
| -18% | -$6.56M | 0.01% | 927 |
|
|
2020
Q3 | $29.4M | Buy |
336,789
+179,332
| +114% | +$15.7M | 0.01% | 851 |
|
|
2020
Q2 | $14.1M | Buy |
157,457
+12,801
| +9% | +$1.29M | 0.01% | 1242 |
|
|
2020
Q1 | $14.4M | Buy |
144,656
+103,495
| +251% | +$11.2M | 0.01% | 1095 |
|
|
2019
Q4 | $4.73M | Sell |
41,161
-14,119
| -26% | -$1.71M | ﹤0.01% | 2191 |
|
|
2019
Q3 | $6.97M | Sell |
55,280
-189,242
| -77% | -$24M | ﹤0.01% | 1828 |
|
|
2019
Q2 | $29.4M | Sell |
244,522
-33,292
| -12% | -$3.28M | 0.01% | 850 |
|
|
2019
Q1 | $24.3M | Buy |
277,814
+99,399
| +56% | +$9.04M | 0.01% | 946 |
|
|
2018
Q4 | $17.9M | Sell |
178,415
-130,295
| -42% | -$13.7M | 0.01% | 1070 |
|
|
2018
Q3 | $35.4M | Sell |
308,710
-216,423
| -41% | -$22.4M | 0.01% | 771 |
|
|
2018
Q2 | $47.1M | Sell |
525,133
-129,596
| -20% | -$10.9M | 0.02% | 589 |
|
|
2018
Q1 | $47.9M | Sell |
654,729
-82,699
| -11% | -$5.67M | 0.02% | 607 |
|
|
2017
Q4 | $42.8M | Sell |
737,428
-44,367
| -6% | -$2.34M | 0.02% | 682 |
|
|
2017
Q3 | $35.1M | Buy |
781,795
+82,387
| +12% | +$3.42M | 0.02% | 743 |
|
|
2017
Q2 | $27.6M | Buy |
699,408
+3,943
| +0.6% | +$162K | 0.01% | 850 |
|
|
2017
Q1 | $28.2M | Buy |
695,465
+55,360
| +9% | +$2.16M | 0.02% | 812 |
|
|
2016
Q4 | $25.7M | Buy |
640,105
+68,509
| +12% | +$2.58M | 0.01% | 882 |
|
|
2016
Q3 | $20.7M | Sell |
571,596
-9,175
| -2% | -$315K | 0.01% | 986 |
|
|
2016
Q2 | $16.8M | Buy |
580,771
+2,844
| +0.5% | +$86K | 0.01% | 1074 |
|
|
2016
Q1 | $20.2M | Buy |
577,927
+4,678
| +0.8% | +$151K | 0.01% | 924 |
|
|
2015
Q4 | $18.5M | Sell |
573,249
-22,207
| -4% | -$720K | 0.01% | 1023 |
|
|
2015
Q3 | $19.2M | Sell |
595,456
-11,873
| -2% | -$447K | 0.01% | 791 |
|
|
2015
Q2 | $25.1M | Sell |
607,329
-27,162
| -4% | -$1.15M | 0.02% | 694 |
|
|
2015
Q1 | $28.5M | Buy |
634,491
+11,391
| +2% | +$476K | 0.02% | 633 |
|
|
2014
Q4 | $23.3M | Sell |
623,100
-34,174
| -5% | -$1.25M | 0.02% | 763 |
|
|
2014
Q3 | $23M | Sell |
657,274
-24,837
| -4% | -$886K | 0.02% | 728 |
|
|
2014
Q2 | $24.1M | Sell |
682,111
-15,674
| -2% | -$524K | 0.02% | 698 |
|
|
2014
Q1 | $22.7M | Buy |
697,785
+35,740
| +5% | +$1.37M | 0.02% | 692 |
|
|
2013
Q4 | $27.9M | Buy |
662,045
+531,650
| +408% | +$21.9M | 0.02% | 609 |
|
|
2013
Q3 | $5.2M | Buy |
130,395
+18,685
| +17% | +$784K | ﹤0.01% | 1559 |
|
|
2013
Q2 | $4.62M | Buy |
+111,710
| New | +$4.52M | ﹤0.01% | 1513 |
|
Other funds holding HAE
VPM
VCM
RRAM
Royal Bank of Canada's HAE Position: Q1 2026 in Review
Royal Bank of Canada reduced its Haemonetics (HAE) stake by 11% in Q1 2026, selling an estimated $7.14M and leaving 857,965 shares worth $48.4M. The position accounts for 0.01% of the portfolio, ranked #930.
Royal Bank of Canada first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $81.9M in Q4 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Royal Bank of Canada held 857,965 shares of Haemonetics worth $48.4M as of Q1 2026.
- Royal Bank of Canada sold 109,628 Haemonetics shares in Q1 2026, an estimated $7.14M.
- Haemonetics made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #930 holding.
- Royal Bank of Canada first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Haemonetics position peaked at $81.9M in Q4 2024.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.